# Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia

> **NCT04010305** · PHASE1 · COMPLETED · sponsor: **BioXcel Therapeutics Inc** · enrollment: 135 (actual)

## Conditions studied

- Agitation
- Schizophrenia

## Interventions

- **DRUG:** Sublingual film containing BXCL501 (Dexmedetomidine)
- **DRUG:** Placebo film

## Key facts

- **NCT ID:** NCT04010305
- **Lead sponsor:** BioXcel Therapeutics Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-22
- **Primary completion:** 2019-07-31
- **Final completion:** 2019-07-31
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2023-02-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04010305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04010305, "Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04010305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*